Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII: c levels

Rossella Marcucci, Rosanna Abbate, Sandra Fedi, Anna Maria Gori, Tamara Brunelli, Vincenza Bruni, Sandra Bucciantini, Serena Micheli, Guglielmina Pepe, Domenico Prisco, Gian Franco Gensini

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Activated protein C (APC) resistance is an established risk factor for venous thromboembolism. In 5% to 10% of patients with venous thromboembolism, the APC resistance phenotype is observed in the absence of factor V Leiden mutation. Moreover, some physiologic and pathologic conditions are associated with an 'acquired' APC resistance, not caused by the Leiden mutation, such as inflammatory diseases, pregnancy, or oral contraceptive therapy. Several studies have demonstrated the effect of menopause on the hemostatic system, but no data are available about APC resistance. We found a high prevalence of APC resistance in postmenopausal women, not associated with factor V Leiden mutation. The mechanism that underlies this acquired APC resistance may be related to the higher levels of factor VIII, which showed a strong inverse correlation with APC resistance, whereas no correlation was found between the normalized APC ratio, factor V levels, and protein S values. Higher levels of factor VIII correlated with a marker of coagulation activation, such as prothrombin fragments 1 plus 2. Therefore, to identify women receiving hormone replacement therapy who have a greater risk for deep venous thrombosis, the APC resistance coagulation test should be used instead of the genetic study.

Original languageEnglish
Pages (from-to)769-772
Number of pages4
JournalAmerican Journal of Clinical Pathology
Volume111
Issue number6
Publication statusPublished - 1999

Fingerprint

Activated Protein C Resistance
Factor VIII
Venous Thromboembolism
Mutation
Factor V
Protein S
Hormone Replacement Therapy
Hemostatics
Oral Contraceptives
Menopause
Protein C
Information Systems
Venous Thrombosis
Phenotype
Pregnancy

Keywords

  • Activated protein C resistance
  • Factor VIII
  • Menopause

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Marcucci, R., Abbate, R., Fedi, S., Gori, A. M., Brunelli, T., Bruni, V., ... Gensini, G. F. (1999). Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII: c levels. American Journal of Clinical Pathology, 111(6), 769-772.

Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII : c levels. / Marcucci, Rossella; Abbate, Rosanna; Fedi, Sandra; Gori, Anna Maria; Brunelli, Tamara; Bruni, Vincenza; Bucciantini, Sandra; Micheli, Serena; Pepe, Guglielmina; Prisco, Domenico; Gensini, Gian Franco.

In: American Journal of Clinical Pathology, Vol. 111, No. 6, 1999, p. 769-772.

Research output: Contribution to journalArticle

Marcucci, R, Abbate, R, Fedi, S, Gori, AM, Brunelli, T, Bruni, V, Bucciantini, S, Micheli, S, Pepe, G, Prisco, D & Gensini, GF 1999, 'Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII: c levels', American Journal of Clinical Pathology, vol. 111, no. 6, pp. 769-772.
Marcucci, Rossella ; Abbate, Rosanna ; Fedi, Sandra ; Gori, Anna Maria ; Brunelli, Tamara ; Bruni, Vincenza ; Bucciantini, Sandra ; Micheli, Serena ; Pepe, Guglielmina ; Prisco, Domenico ; Gensini, Gian Franco. / Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII : c levels. In: American Journal of Clinical Pathology. 1999 ; Vol. 111, No. 6. pp. 769-772.
@article{3aedecf60de44480b7c80d35550541eb,
title = "Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII: c levels",
abstract = "Activated protein C (APC) resistance is an established risk factor for venous thromboembolism. In 5{\%} to 10{\%} of patients with venous thromboembolism, the APC resistance phenotype is observed in the absence of factor V Leiden mutation. Moreover, some physiologic and pathologic conditions are associated with an 'acquired' APC resistance, not caused by the Leiden mutation, such as inflammatory diseases, pregnancy, or oral contraceptive therapy. Several studies have demonstrated the effect of menopause on the hemostatic system, but no data are available about APC resistance. We found a high prevalence of APC resistance in postmenopausal women, not associated with factor V Leiden mutation. The mechanism that underlies this acquired APC resistance may be related to the higher levels of factor VIII, which showed a strong inverse correlation with APC resistance, whereas no correlation was found between the normalized APC ratio, factor V levels, and protein S values. Higher levels of factor VIII correlated with a marker of coagulation activation, such as prothrombin fragments 1 plus 2. Therefore, to identify women receiving hormone replacement therapy who have a greater risk for deep venous thrombosis, the APC resistance coagulation test should be used instead of the genetic study.",
keywords = "Activated protein C resistance, Factor VIII, Menopause",
author = "Rossella Marcucci and Rosanna Abbate and Sandra Fedi and Gori, {Anna Maria} and Tamara Brunelli and Vincenza Bruni and Sandra Bucciantini and Serena Micheli and Guglielmina Pepe and Domenico Prisco and Gensini, {Gian Franco}",
year = "1999",
language = "English",
volume = "111",
pages = "769--772",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "6",

}

TY - JOUR

T1 - Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII

T2 - c levels

AU - Marcucci, Rossella

AU - Abbate, Rosanna

AU - Fedi, Sandra

AU - Gori, Anna Maria

AU - Brunelli, Tamara

AU - Bruni, Vincenza

AU - Bucciantini, Sandra

AU - Micheli, Serena

AU - Pepe, Guglielmina

AU - Prisco, Domenico

AU - Gensini, Gian Franco

PY - 1999

Y1 - 1999

N2 - Activated protein C (APC) resistance is an established risk factor for venous thromboembolism. In 5% to 10% of patients with venous thromboembolism, the APC resistance phenotype is observed in the absence of factor V Leiden mutation. Moreover, some physiologic and pathologic conditions are associated with an 'acquired' APC resistance, not caused by the Leiden mutation, such as inflammatory diseases, pregnancy, or oral contraceptive therapy. Several studies have demonstrated the effect of menopause on the hemostatic system, but no data are available about APC resistance. We found a high prevalence of APC resistance in postmenopausal women, not associated with factor V Leiden mutation. The mechanism that underlies this acquired APC resistance may be related to the higher levels of factor VIII, which showed a strong inverse correlation with APC resistance, whereas no correlation was found between the normalized APC ratio, factor V levels, and protein S values. Higher levels of factor VIII correlated with a marker of coagulation activation, such as prothrombin fragments 1 plus 2. Therefore, to identify women receiving hormone replacement therapy who have a greater risk for deep venous thrombosis, the APC resistance coagulation test should be used instead of the genetic study.

AB - Activated protein C (APC) resistance is an established risk factor for venous thromboembolism. In 5% to 10% of patients with venous thromboembolism, the APC resistance phenotype is observed in the absence of factor V Leiden mutation. Moreover, some physiologic and pathologic conditions are associated with an 'acquired' APC resistance, not caused by the Leiden mutation, such as inflammatory diseases, pregnancy, or oral contraceptive therapy. Several studies have demonstrated the effect of menopause on the hemostatic system, but no data are available about APC resistance. We found a high prevalence of APC resistance in postmenopausal women, not associated with factor V Leiden mutation. The mechanism that underlies this acquired APC resistance may be related to the higher levels of factor VIII, which showed a strong inverse correlation with APC resistance, whereas no correlation was found between the normalized APC ratio, factor V levels, and protein S values. Higher levels of factor VIII correlated with a marker of coagulation activation, such as prothrombin fragments 1 plus 2. Therefore, to identify women receiving hormone replacement therapy who have a greater risk for deep venous thrombosis, the APC resistance coagulation test should be used instead of the genetic study.

KW - Activated protein C resistance

KW - Factor VIII

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=0033008338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033008338&partnerID=8YFLogxK

M3 - Article

C2 - 10361512

AN - SCOPUS:0033008338

VL - 111

SP - 769

EP - 772

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 6

ER -